$6.04
-0.34[-5.33%]
Last update: 9:00AM Get Real Time Here
Palisade Bio
(NASDAQ:PALI)Palisade Bio Stock (NASDAQ:PALI), Analyst Ratings, Price Targets, Predictions
Palisade Bio Inc has a consensus price target of $19.25, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Maxim Group, Maxim Group, and Maxim Group on May 1, 2024, April 16, 2024, and November 17, 2023. With an average price target of $15.5 between Maxim Group, Maxim Group, and Maxim Group, there's an implied 156.62% upside for Palisade Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
Ladenburg Thalmann
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Palisade Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/01/2024 | Buy Now | 272.52% | Maxim Group | Naz Rahman | → $22.5 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2024 | Buy Now | 272.52% | Maxim Group | Naz Rahman | $22.5 → $22.5 | Maintains | Buy | Get Alert |
| 11/17/2023 | Buy Now | -75.17% | Maxim Group | Naz Rahman | → $22.5 | Upgrade | Hold → Buy | Get Alert |
| 05/16/2023 | Buy Now | 164.9% | Ladenburg Thalmann | Aydin Huseynov | $375 → $240 | Maintains | Buy | Get Alert |
| 03/30/2023 | Buy Now | 727.81% | Maxim Group | Naz Rahman | → $750 | Upgrade | Hold → Buy | Get Alert |
| 08/19/2022 | Buy Now | — | Maxim Group | Naz Rahman | — | Downgrade | Buy → Hold | Get Alert |
| 02/02/2022 | Buy Now | -17.22% | Ladenburg Thalmann | Aydin Huseynov | → $3750 | Initiates | → Buy | Get Alert |
| 08/31/2021 | Buy Now | 15.89% | Maxim Group | Naz Rahman | → $5250 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Palisade Bio (PALI)?
The latest price target for Palisade Bio (NASDAQ: PALI) was reported by Maxim Group on May 1, 2024. The analyst firm set a price target for $22.50 expecting PALI to rise to within 12 months (a possible 272.52% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Palisade Bio (PALI)?
The latest analyst rating for Palisade Bio (NASDAQ: PALI) was provided by Maxim Group, and Palisade Bio reiterated their buy rating.
When was the last upgrade for Palisade Bio (PALI)?
The last upgrade for Palisade Bio Inc happened on November 17, 2023 when Maxim Group raised their price target to $1.5. Maxim Group previously had a hold for Palisade Bio Inc.
When was the last downgrade for Palisade Bio (PALI)?
The last downgrade for Palisade Bio Inc happened on August 19, 2022 when Maxim Group changed their price target from N/A to N/A for Palisade Bio Inc.
When is the next analyst rating going to be posted or updated for Palisade Bio (PALI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Palisade Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Palisade Bio was filed on May 1, 2024 so you should expect the next rating to be made available sometime around May 1, 2025.
Is the Analyst Rating Palisade Bio (PALI) correct?
While ratings are subjective and will change, the latest Palisade Bio (PALI) rating was a reiterated with a price target of $0.00 to $22.50. The current price Palisade Bio (PALI) is trading at is $6.04, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.